A febrile illness is a common reason for both adults and children to attend an accident and emergency department. The identi®cation of the one patient with meningitis out of many with trivial viral infections remains a dif®cult task. Even once the diagnosis is made clinically, the subsequent investigation and management of the patient remains controversial, with opinions often in¯uenced by one or two adverse experiences. In this review, we discuss the diagnostic and management issues relevant to the emergency care specialist, paediatrician or physician faced with such patients. The detailed immediate care of patients requiring respiratory and cardiovascular support, particularly those with associated septicaemic shock, has been reviewed elsewhere 1 .
WHEN SHOULD WE SUSPECT BACTERIAL MENINGITIS?
It has been suggested that bacterial meningitis presents in two formsÐ®rst, an acute presentation with a history of less than 24 hours which is associated with a poor outcome; secondly, a more insidious form which is dif®cult to detect but has a better outcome 2 . Few doctors would want to miss the opportunity to interrupt the pathogenic process at an early stage. Thus when considering bacterial meningitis, it is helpful to understand the essential pathogenic processes that mediate this disease 3 . In most cases the organisms cross the meninges from the bloodstream in the course of a bacteraemic illness. Patients with non-speci®c signs and symptoms may be bacteraemic with only limited passage of organisms across the blood±brain barrier (BBB); therefore the classic signs of meningitis may be absent (see below). Features of meningism become more prominent once bacterial invasion across the BBB is established. The release of bacterial toxins such as endotoxin, peptidoglycan and teichoic acid initiates an in¯ammatory process that leads to impairment of BBB function, cerebral oedema and raised intracranial pressure. Increased leukocyte traf®c across the blood vessel wall triggers cerebral vascular thrombosis. The combination of globally reduced cerebral blood-¯ow and focal ischaemia results in neuronal injury and cerebral damage which manifest clinically as coma, seizures and focal neurological signs.
It is therefore important to appreciate that, while the characteristic featuresÐfever, headache, vomiting, and signs of meningeal irritation, with or without a petechial rashÐare easy to recognize, the signs of meningitis in its early stages are often non-speci®c and require a high index of suspicion 4, 5 . Fever may be absent initially in up to 30% of individuals with bacterial meningitis 6 . Between 20% and 30% of patients with meningitis do not have signs of meningism at presentation, particularly the very young, the elderly and the immunocompromised 5±7 . The diagnosis of meningitis should be carefully considered in any patient with confusion, irritability or lethargy, with or without a fever. Previous antibiotic therapy is commonplace and may mask the true signi®cance of the presenting illness. Therefore, overinvestigation and overtreatment are preferable to missing the diagnosis and losing an opportunity to intervene at a crucial stage.
WHAT ARE THE BACTERIOLOGICAL CAUSES OF MENINGITIS?
The Haemophilus in¯uenzae type b (Hib) polysaccharideconjugate vaccine has virtually eliminated what was once the commonest meningeal pathogen in children under 5 years in the UK (fewer than 40 cases per year) 8 . Neisseria meningitidis and Streptococcus pneumoniae are now the commonest causes of community-acquired bacterial meningitis overall. However, their relative importance varies considerably with age ( Figure 1 ). In the neonatal period, the group B streptococcus followed by Gram-negative bacilli, S. pneumoniae and Listeria monocytogenes are the prominent meningeal pathogens. In children older than 3 months and in young adults the most frequent cause of bacterial meningitis is N. meningitidis, followed by S. pneumoniae. Adults over the age of 50 years are less commonly affected by N. meningitidis with S. pneumoniae predominating, followed by Gram-negative bacilli and L. monocytogenes. A rare but serious form of bacterial meningitis is caused by Mycobacterium tuberculosis. This organism can affect patients of all ages and should be considered in any atypical presentation of meningitis, particularly in patients from an endemic area or with an insidious illness 9 .
WHAT ARE THE RISKS AND BENEFITS OF LUMBAR PUNCTURE?
Over the past 10 years there has been a strong move away from performance of lumbar puncture (LP) in all patients with suspected meningitis. A common argument is that, now we have potent antibiotics, a LP will not affect the management of such patients. Indeed it has been maintained that a LP may be positively hazardous. While there are speci®c and well accepted contraindications to LP in patients with meningitis (see Box 1) 1,10 , we believe that, in the absence of these, this investigation is crucial for optimal management and, provided that it can be done within 30 minutes of initial assessment, will not seriously delay treatment. The association between LP and cerebellar tonsillar or uncal herniation is unproven 7,10 and has not been reported in the absence of the speci®c contraindications listed in Box 1 11 . A LP offers con®rmation of the diagnosis and may be particularly important in adult patients and the immunocompromised in whom the differential diagnosis is wide. Bacteriological cultures of cerebrospinal uid (CSF) may yield vital data regarding aetiology and antibiotic sensitivities. Finally, identi®cation of the aetiological agent may provide important prognostic information. The mortality associated with bacterial meningitis varies considerably with age and aetiology. While the overall mortality from bacterial meningitis is around 11%, it is only 3% for meningococcal meningitis in the absence of septicaemia and reaches 25% for pneumococcal meningitis. Furthermore, these mortality ®gures exceed 50% for patients with pneumococcal meningitis over 60 years of age (unpublished analysis of death registrations, Of®ce for National Statistics). The morbidity associated with the two commonest causes of bacterial meningitis also differs greatly. Deafness occurs in 2% of cases of meningococcal infection but in more than 10% of cases of pneumococcal disease 12, 13 .
If antibiotics are given beforehand, LP can still be diagnostic. Numerous studies have now shown that, even after the administration of intravenous antibiotics, the diagnostic cellular and biochemical changes in the CSF persist for at least 48 hours 14 . In the context of a negative Gram stain and CSF culture and a negative throat swab culture, novel approaches to the latex agglutination test for bacterial antigen and polymerase chain reactions for N. meningitidis may prove invaluable 15±17 .
SHOULD WE PERFORM A COMPUTED TOMOGRAPHIC (CT) SCAN ON EVERY PATIENT?
After the clinical diagnosis of bacterial meningitis, it has become common practice to arrange a CT brain scan to exclude raised intracranial pressure before lumbar puncture 18 . This approach has three important drawbacks: ®rst, intracranial pressure (ICP) is very common amongst children and adults with meningitis 7, 19 and clinically signi®cant raised ICP cannot be ruled out by brain CT 10, 20 ; second, it is hazardous to transport patients to a CT scanner before they have been adequately stabilized; and third, the inevitable delay in undertaking the CT scan requires that empirical antibiotics are given in the interim, thus lessening the diagnostic yield from a subsequent LP. Box 1 Speci®c contraindications to lumbar puncture in patients with meningitis maximize venous drainage. Intravenous mannitol reduces extracellular¯uid accumulation and may be useful for managing acute changes in intracranial pressure and incipient coning. Another argument made for CT is that it will exclude lesions requiring neurosurgical intervention. Brain imaging (ideally magnetic resonance) can indeed be very useful in the investigation of the immunocompromised with suspected cerebral infection and may de®ne a dural defect 7 in adults with otitis media or mastoiditis. However, in the context of community-acquired meningitis this approach seldom identi®es conditions requiring neurosurgical intervention such as cerebral abscess or hydrocephalus 7, 20 . We suggest that a CT scan is indicated in only a small proportion of patients before lumbar puncture but acknowledge that, particularly in adults, a CT during the acute phase may be reassuring.
WHICH ANTIBIOTICS?
Except in cases where the patient is well and the diagnosis very uncertain, antibiotics should be administered empirically while the result of a LP is awaited. The selection of the optimal antibiotic should be based on the following four factorsÐthe spectrum of pathogens causing meningitis in different age groups; the changing pattern of antimicrobial resistance; the pharmacological properties of the antibiotics available, and the results of therapeutic trials 21, 22 . Our current recommendations for initial antibiotic treatment of bacterial meningitis are shown in Table 1 . In infants between one and three months of age a combination of ampicillin and cefotaxime is a logical choice since cefotaxime provides cover for both neonatal and infant pathogens and ampicillin is effective against L. monocytogenes. Likewise in the immunocompromised or elderly adult, ampicillin should be included as part of empirical therapy. Penicillin-resistant meningococci are emerging worldwide 23 , as are chloramphenicol-resistant strains 24 , but these have not resulted in treatment failures and almost all strains in the UK remain sensitive. N. meningitidis continues to be sensitive to the third-generation cephalosporins and concern has therefore focused on pneumococci resistant to single or multiple antibiotics 25, 26 . In the United States, more than a quarter of pneumococcal isolates are resistant to penicillin and in countries such as Hungary, Spain and South Africa more than half. Indeed, documented microbiological failure has occurred in the treatment of pneumococcal meningitis with third-generation cephalosporins 26 . In the UK, the level of penicillin resistance is increasing, having reached 6.5% of all invasive pneumococcal isolates reported in the ®rst quarter of 1999 (Public Health Laboratory Service data). Fortunately, this penicillin resistance is nearly always low-level and cephalosporin resistance is rare. At the time of writing, routine use of vancomycin in addition to a third-generation cephalosporin for community-acquired meningitis is not justi®ed in the UK; however, we suggest that, in view of the increased likelihood of cephalosporin resistance, vancomycin should be added to the treatment regimen for any patient coming from an area where high levels of penicillin resistance are endemic. The addition of rifampicin to vancomycin or the administration of vancomycin intraventricularly has been recommended by some authorities 26 .
WHAT IS THE ROLE OF CORTICOSTEROIDS?
Much of the cerebral damage that occurs in bacterial meningitis is due to the host-mediated in¯ammatory response (see above). This cascade of events is triggered by bacterial toxins, a phenomenon that is exacerbated by antibiotic treatment 27 . While several adjunctive anti-in¯ammatory agents have been suggested 3, 27 , only corticosteroids have been extensively tested in clinical trials. On the basis of convincing improvements in morbidity (deafness or neurological de®cit) but not mortality, adjunctive dexamethasone therapy for suspected bacterial meningitis, either before or at the time of antibiotic administration, was commonly adopted in North America and Europe 28±30 . However, whether this approach should continue requires re-examination. First, the steroid trials were largely conducted on children with Hib meningitis (now a rare disease in these countries). Second, there is a paucity of trial data on adults with meningitis 31, 32 . Third, there is concern that the use of steroids in penicillinresistant pneumococcal meningitis may hinder sterilization 33 . At a time when the majority of patients with meningitis in the UK have meningococcal disease (a 3% mortality and deafness in fewer than 2% of individuals), it is therefore dif®cult to justify the widespread use of these potentially harmful agents. In view of the ef®cacy of corticosteroids in experimental meningococcal and pneumococcal meningitis and a few, albeit¯awed, studies suggesting clinical ef®cacy, it is clear that further clinical trials are required. We suggest that the selective administration of dexamethasone to patients who have a bad predicted mortality or morbidity may be a more rational approach to future trial design 7, 34 .
WHAT IS THE CORRECT FLUID MANAGEMENT?
As medical students or junior doctors many of us were taught to restrict¯uid intake in meningitis patients to half to two-thirds of their normal daily requirement. This policy was based on the common ®nding of hyponatraemia in such patients and the observation that hyponatraemia correlates with severity of disease and a poor neurological outcome. In addition, serum antidiuretic hormone (ADH) is raised in 7±88% of cases (thought to be inappropriate secretion); and, in one study,¯uid restriction was shown to be associated with a lower mortality 35 . However,¯uid restriction may prejudice circulating volume and therefore cerebral blood-¯ow. In laboratory animals¯uid restriction increases CSF lactate and decreases CSF glucose 36 . ADH becomes normal more quickly with rehydration than with uid restriction 37 . Paradoxically, one study has shown¯uid restriction to be associated with a higher mortality. On balance, we suggest that patients with circulatory shock should be resuscitated aggressively (see Pollard et al. 1 for details), dehydration should be addressed carefully,¯uid balance should be checked frequently and maintenancē uids should be given with care, orally if possible.
CONCLUSIONS
In conclusion, bacterial meningitis remains a dif®cult diagnosis to make. With an increasing incidence of pneumococcal penicillin resistance worldwide, management of such patients is becoming increasingly problematic. In recent years there has been a distinct shift away from the use of lumbar puncture and an increase in the use of CT brain scans in the investigation of children and adults with meningitis. This cannot be justi®ed on the basis of the published work. Figure 2 summarizes our views on the emergency management of a patient with suspected bacterial meningitis. We emphasize, however, that every patient must be dealt with individually, by the most experienced clinician available. 
